Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics. (Q55461129)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

0 references

author name string

Jun Liang

1

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Xianli Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Shao Xie

3

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Xiuping Zhou

4

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Qiong Shi

5

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Jinxia Hu

6

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Weifeng Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Weifeng Qi

8

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Rutong Yu

9

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

publication date

27 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

31

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

4

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

899

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Primary brain tumours in adults.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Malignant gliomas in adults

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Central nervous system tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Gliomagenesis: genetic alterations and mouse models

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Targeting the ubiquitin system in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

The expression patterns of deubiquitinating enzymes, USP22 and Usp22

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Increased expression of ubiquitin‐specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

The ubiquitin hydrolase USP22 contributes to 3'-end processing of JAK-STAT-inducible genes

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

The Bmi-1/NF-κB/VEGF story: another hint for proteasome involvement in glioma angiogenesis?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Bmi-1 promotes glioma angiogenesis by activating NF-κB signaling

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

21 January 2018

Copper induces cellular senescence in human glioblastoma multiforme cells through downregulation of Bmi-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24573640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RNA interference-mediated USP22 gene silencing promotes human brain glioma apoptosis and induces cell cycle arrest

1 reference

https://pubmed.ncbi.nlm.nih.gov/24573640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The present and future management of malignant brain tumours: surgery, radiotherapy, chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24573640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24573640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Co-expression of USP22 and BMI-1 May Promote Cancer Progression and Predict Therapy Failure in Gastric Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24573640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implication of USP22 in the Regulation of BMI-1, c-Myc, p16INK4a, p14ARF, and Cyclin D2 Expression in Primary Colorectal Carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24573640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elderly and poor prognosis patients with high grade glioma: hypofractionated radiotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24573640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-014-0899-2

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/24573640

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55461129&oldid=2212778851"